Quest Diagnostics to Speak at Citi's 2025 Global Healthcare Conference
Rhea-AI Summary
Quest Diagnostics (NYSE: DGX) announced that Sam Samad, executive vice president and chief financial officer, will speak at Citi's 2025 Global Healthcare Conference in Miami on Tuesday, December 2, 2025 at 3:15 p.m. ET.
The session will be a fireside chat with Q&A and will be webcast live on the company's investor relations page at ir.QuestDiagnostics.com. An archived webcast will be posted within 24 hours and will remain available through January 2, 2026.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, DGX declined 0.45%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
The fireside chat and Q&A session will be webcast live during the conference on the company's investor relations page, which can be accessed at ir.QuestDiagnostics.com. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until January 2, 2026.
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-citis-2025-global-healthcare-conference-302603103.html
SOURCE Quest Diagnostics